183 related articles for article (PubMed ID: 26866096)
1. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
[TBL] [Abstract][Full Text] [Related]
2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
3. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
Lee E; Redman M; Burgess G; Win N
Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
[TBL] [Abstract][Full Text] [Related]
4. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
Dinardo CL; Bonifácio SL; Mendrone A
Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
[TBL] [Abstract][Full Text] [Related]
5. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
Thakral B; Saluja K; Sharma RR; Marwaha N
Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
Natukunda B; Schonewille H; van de Watering L; Brand A
Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
[TBL] [Abstract][Full Text] [Related]
7. [Identification of alloantibodies and their associations: balance sheet of a year at the Auvergne-Loire French Blood Establishment].
Duboeuf S; Flourié F; Courbil R; Benamara A; Rigal E; Cognasse F; Garraud O
Transfus Clin Biol; 2012 Dec; 19(6):358-65. PubMed ID: 23159062
[TBL] [Abstract][Full Text] [Related]
8. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
[TBL] [Abstract][Full Text] [Related]
9. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review.
Havemann H; Lichtiger B
Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy.
Koelewijn JM; Vrijkotte TG; de Haas M; van der Schoot CE; Bonsel GJ
BJOG; 2009 Apr; 116(5):655-64. PubMed ID: 19210505
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Pretransplant Donor-Specific Alloantibodies With Different Crossmatch Techniques.
Moszkowska G; Zieliński M; Zielińska H; Dukat-Mazurek A; Dębska-Zielkowska J; Dębska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2018; 50(6):1625-1630. PubMed ID: 30056871
[TBL] [Abstract][Full Text] [Related]
12. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
Pereira A; Mazzara R; Gelabert A; Castillo R
Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
[TBL] [Abstract][Full Text] [Related]
14. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
16. Role of enzyme-treated cells in RBC antibody screening using the gel test: a study of anti-RH1, -RH2, and -RH3 antibodies.
Conne J; Schneider P; Tissot JD
J Clin Lab Anal; 2007; 21(2):61-6. PubMed ID: 17385674
[TBL] [Abstract][Full Text] [Related]
17. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
Pinkerton PH; Coovadia AS; Goldstein J
Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
[TBL] [Abstract][Full Text] [Related]
18. Red cell immunization in beta thalassaemia major.
Bhatti FA; Salamat N; Nadeem A; Shabbir N
J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
[TBL] [Abstract][Full Text] [Related]
19. Pathology consultation on electronic crossmatch.
Mazepa MA; Raval JS; Park YA;
Am J Clin Pathol; 2014 May; 141(5):618-24. PubMed ID: 24713731
[TBL] [Abstract][Full Text] [Related]
20. [Transfusion management of patients with red blood cell antibodies].
Bujandrić NB; Grujić JN; Krga-Milanović MM
Med Pregl; 2013; 66(11-12):491-6. PubMed ID: 24575638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
